- Home
- THCH vs PDSB Comparison
THCH vs PDSB Comparison
Compare THCH & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THCH
- PDSB
- Stock Information
- Founded
- THCH 2018
- PDSB 2005
- Country
- THCH China
- PDSB United States
- Employees
- THCH 1577
- PDSB N/A
- Industry
- THCH Blank Checks
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- THCH Finance
- PDSB Health Care
- Exchange
- THCH Nasdaq
- PDSB Nasdaq
- Market Cap
- THCH 84.8M
- PDSB 72.2M
- IPO Year
- THCH N/A
- PDSB N/A
- Fundamental
- Price
- THCH $2.77
- PDSB $1.62
- Analyst Decision
- THCH
- PDSB Strong Buy
- Analyst Count
- THCH 0
- PDSB 2
- Target Price
- THCH N/A
- PDSB $10.00
- AVG Volume (30 Days)
- THCH 14.0K
- PDSB 855.2K
- Earning Date
- THCH 06-24-2025
- PDSB 08-12-2025
- Dividend Yield
- THCH N/A
- PDSB N/A
- EPS Growth
- THCH N/A
- PDSB N/A
- EPS
- THCH N/A
- PDSB N/A
- Revenue
- THCH $190,593,061.00
- PDSB N/A
- Revenue This Year
- THCH N/A
- PDSB N/A
- Revenue Next Year
- THCH N/A
- PDSB N/A
- P/E Ratio
- THCH N/A
- PDSB N/A
- Revenue Growth
- THCH N/A
- PDSB N/A
- 52 Week Low
- THCH $2.15
- PDSB $0.85
- 52 Week High
- THCH $5.15
- PDSB $4.42
- Technical
- Relative Strength Index (RSI)
- THCH 50.83
- PDSB 54.15
- Support Level
- THCH $2.58
- PDSB $1.53
- Resistance Level
- THCH $2.75
- PDSB $1.85
- Average True Range (ATR)
- THCH 0.13
- PDSB 0.14
- MACD
- THCH 0.00
- PDSB -0.01
- Stochastic Oscillator
- THCH 45.56
- PDSB 44.86
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.